宋云華

【摘 要】目的：探究對(duì)慢性腎臟病5期患者應(yīng)用一體化治療方式展開(kāi)診治處理的臨床療效。方法：選取2016年9月至2017年8月我院接收并采取相應(yīng)診治處理及門(mén)診隨訪的慢性腎臟病5期患者110例作為研究樣本，全部患者均為我院及上級(jí)醫(yī)院依據(jù)相關(guān)標(biāo)準(zhǔn)確診的慢性腎臟病5期患者。將其隨機(jī)分為兩組，即對(duì)照組和觀察組，每組55例。對(duì)照組采取cuff導(dǎo)管血液透析，透析治療前未開(kāi)展過(guò)一體化治療措施；觀察組透析前已采取一體化治療措施及適時(shí)創(chuàng)建動(dòng)靜脈內(nèi)瘺，現(xiàn)采取內(nèi)瘺透析并繼續(xù)采取一體化治療。觀察并比較兩組患者臨床診治結(jié)果，治療前后血鈣、血磷、血紅蛋白水平的變化情況。結(jié)果：給予對(duì)應(yīng)診治處理后，觀察組患者臨床診治有效率相較于對(duì)照組對(duì)應(yīng)數(shù)值，提升趨勢(shì)顯著（P<0.05）；兩組患者的血鈣、血磷、血紅蛋白水平相較于治療前，均呈現(xiàn)顯著改善趨勢(shì)，且觀察組患者在血鈣、血磷、血紅蛋白水平等方面的變化情況顯著優(yōu)于對(duì)照組（P<0.05）。結(jié)論：對(duì)慢性腎臟病5期患者應(yīng)用一體化治療方式展開(kāi)診治處理，臨床診治結(jié)果顯著，對(duì)患者臨床診治有效率的提升具有積極作用及重要意義，能夠?qū)崿F(xiàn)對(duì)患者體內(nèi)血磷含量的有效清除，改善患者機(jī)體鈣磷代謝異常狀況，同時(shí)對(duì)患者生命質(zhì)量的改善具有積極的促進(jìn)作用。

【關(guān)鍵詞】一體化治療；慢性腎臟病；臨床療效

Abstract Objective： To explore the clinical efficacy of integrated treatment for patients with chronic renal disease. Methods： to choose between September 2016 and August 2016 our hospital receives and adopt corresponding diagnosis and treatment and outpatient follow-up of 110 cases of patients with chronic kidney disease （CKD） 5） as the research sample， all patients were diagnosed and superior in our hospital according to relevant standards of CKD stage 5 patients. They were randomly divided into two groups， the control group and the observation group， each with 55 cases. The control group was treated with cuff catheter hemodialysis， and no integrated treatment was carried out before dialysis. The integrated treatment and the timely creation of arteriovenous fistula had been taken before hemodialysis， and the internal fistula dialysis was carried out and the integrative treatment was continued. The results of clinical diagnosis and treatment of the two groups were observed and compared with the changes of blood calcium， phosphorus and hemoglobin levels before and after treatment. Results： after treatment and treatment， the clinical diagnosis and treatment efficiency of the observation group was significantly higher than that of the control group （P< 0.05）. Two groups of patients with the blood of the blood calcium， phosphorus， hemoglobin levels compared with before treatment， tend to significantly improve， and the observation group of patients in blood calcium and blood phosphorus， the change of the respect such as hemoglobin level was significantly better than that of control group （P < 0.05）. Conclusion： for patients with chronic kidney disease （CKD） 5） application integration treatment on diagnosis and treatment， clinical diagnosis and treatment results significantly， has a positive effect to the promotion of clinical treatment of efficient and significance， can achieve the patient's body effectively remove blood phosphorus content， improving the body calcium phosphate metabolic abnormalities in patients with， at the same time on the improvement of the quality of life in patients with a positive role in promoting.